课题基金 / 基金详情

项目摘要

项目成果

ALAN A ADEREM的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):先天免疫系统是抵抗病原体的第一道防线。先天免疫细胞缺乏适应性免疫系统的精确特异性,但为了以可测量的方式做出反应,它们必须能够针对特定病原体调整其反应。因此,这些细胞已经进化出模式识别受体,包括Toll样受体(TLR),其识别微生物特有的保守分子模式,这在宿主中没有发现。虽然对TLR介导免疫应答的机制了解很多,但许多关键问题仍未得到解答。这些的核心是TLR信号通路的所有组件的完整知识,并了解这些组件的架构安排如何导致宿主防御的适当协调。我们利用系统生物学的工具来发现Sharpin,TLR信号传导的一种新成分,我们对该蛋白的初步研究改变了我们对TLR通路结构的理解。我们已经证明,Sharpin的行为水平的NEMO-含有IKK复合物和控制一个新的分支点在TLR 2/NF-?B途径是Th 1细胞因子产生所必需的。在本提案中,我们将:1.确定Sharpin通过染色质结构的表观遗传修饰和增强体形成影响TLR依赖性基因转录反应的机制。2.描述Sharpin通过IKK复合物转导TLR 2/MyD 88信号以调节转录反应的方式。3.确定Sharpin在体内控制对细菌病原体的先天性和适应性免疫应答中的作用。拟议的研究将推进我们的TLR 2/MyD 88通路,NF-?B激活、先天免疫基因的表观遗传调节以及先天免疫细胞指示适应性应答的潜在机制。
英文摘要
DESCRIPTION (provided by applicant): The innate immune system is the first line of defense against pathogens. Innate immune cells lack the exquisite specificity of the adaptive immune system, yet in order to respond in a measured way they must be able to tailor their response to the specific pathogen. These cells have therefore evolved pattern recognition receptors including the Toll-like receptors (TLRs) that recognize conserved molecular patterns characteristic of the microbe, which are not found within the host. While much is known about the mechanisms through which TLRs mediate immune responses, a number of critical questions remain unanswered. Central to these is a complete knowledge of all the components of the TLR signaling pathways and an understanding of how the architectural arrangement of these components leads to the appropriate coordination of host defense. We have utilized the tools of systems biology to discover Sharpin, a novel component of TLR signaling, and our preliminary studies of the protein have altered our understanding of the architecture of the TLR pathway. We have demonstrated that Sharpin acts at the level of the NEMO-containing IKK complex and controls a novel branch point in the TLR2/NF-?B pathway that is necessary for the production of Th1 cytokines. In this proposal, we will: 1. Determine the mechanism by which Sharpin influences transcriptional responses of TLR- dependent genes through epigenetic modification of chromatin structure and enhanceosome formation. 2. Delineate the manner by which Sharpin transduces TLR2/MyD88 signals through the IKK complex to regulate transcriptional responses. 3. Determine the role of Sharpin in controlling innate and adaptive immune responses to bacterial pathogens in vivo. The proposed study will advance our knowledge of the TLR2/MyD88 pathway, NF-?B activation, epigenetic regulation of innate immune genes, and mechanisms underlying the instruction of adaptive responses by innate immune cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Mechanisms of Disease Progression
  • 批准号:
    10339373
  • 项目类别:
  • 资助金额:
    $95.12万
  • 财政年份:
    2018
  • 负责人:
    ALAN A ADEREM
  • 依托单位:
Adminstrative Core
  • 批准号:
    10339370
  • 项目类别:
  • 资助金额:
    $19.2万
  • 财政年份:
    2018
  • 负责人:
    ALAN A ADEREM
  • 依托单位:
Omics for TB: Response to Infection and Treatment
  • 批准号:
    10339369
  • 项目类别:
  • 资助金额:
    $334.54万
  • 财政年份:
    2018
  • 负责人:
    ALAN A ADEREM
  • 依托单位:
Omics for TB Disease Progression (OTB)
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
库否细胞(Kupffer cells)受体PirB/LILRB2在非酒精性脂肪性肝炎中的作用及机制研究
  • 批准号:
    82470907
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2024
  • 负责人:
    余学锋
  • 依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位: